Topaze Televitale and Albus merge in order to become a leading software publisher for paramedical professions

Paris, October 3, 2019

With the support of Extens, Capital Croissance and Bpifrance, Topaze Televitale and Albus merge in order to become a leading software publisher for paramedical professions

Idlog Group, publisher – through its subsidiaries Idea and Televitale – of software solutions for medical and paramedical professionals called Topaze and Télévitale, and Snal Group, publisher of Albus, applications of reference of liberal nurses, announce their merger.

The two groups, created in 1987, together equip nearly 30,000 health auxiliaries, including more than 17,000 nurses, 5 500 physiotherapists and nearly 400 nursing centers, using the software Topaze, Albus et al. Télévitale.

The new Group becomes a key player in the industry of software for paramedical professions in France. Solutions cover the whole  functional chain: constitution of the file of care, organization and planning of the activity, invoicing, teletransmission, etc. They are positioned on the market as key players in terms of innovation, like the 100% SaaS solution, Albus Air.

The reference shareholders of the new group are Arthema, represented by Jean Marc and Brice Salvan, as well as historic shareholders of Snal: funds managed by Extens, an investment firm dedicated to e-health, Capital Croissance, PE funds for SMEs and midcaps, and Bpifrance.

Jean-Marc Salvan, Founder and President of Idlog and Idea, declares: « In this month of October 2019, the company (Idea) celebrates 32 years of existence and development in the field of computing at the service of paramedical and medical professions. As I like to say, birthdays are only as good as bridges thrown into the future. Also, I am delighted with this great future project that brings our companies together. The complementary expertises of our teams and the quality of the dialogue that has taken place for the success of this merger, make this new phase of our companies’ life totally exciting.

Gaël Fierro, Chief Executive Officer of Snal, continues: « In an ever more demanding regulatory context on the part of the public authorities and the evolution of expectations in the field of health informatics, it is vital for key players to join forces in order to support clients and enable them to improve the efficiency of care, coordination between different professionals and relationship with patients. The alliance with Idea and Televitale allows us to capitalize on strong brands and expert teams with very complementary skills. We are very excited to start working together. « 

Stakeholders and advisers for the operation:


▪ Extens: Quentin Jacomet, Cédric Berger
▪ Capital croissance: Cédric Boxberger, Maxime Peronnin
▪ Bpifrance: Julie Regnier, François Picarle

▪ Idlog Lawyers: Alcya (Laurent Simon, Magalie Revillon Persat)
▪ Snal lawyers: Chammas & Marcheteau (Nicolas Lecocq, Jérôme Chapron, Bastien Deroch)
▪ Banks lawyers: Simmons & Simmons (Colin Millar, Galina Petrova)
▪ Due diligence: Advance Capital (Olivier Mortier, Thomas Le Bras)
▪ Due diligence IT: Make it Work (Frédéric Thomas)

Bank financing:

▪ Broker: Le Comptoir Financier (Damien Mina)
▪ Arranger: BPRP (Virginie Rojo and Pinto, Chekib Ben Salah)
▪ La Banque Postale: (Yohann Amyot, Thomas Dechatre)
▪ Crédit du Nord: Romain Picciotto
▪ CIC Est: Gautier André, Valérie Petitjean

About Extens:

Extens is an investment company dedicated to e-health in Europe, created by a management team that brings together entrepreneurial success in health software and capital growth performance.

Extens aims to invest as a reference shareholder mainly in France and opportunistically in Western Europe. It injects amounts ranging from € 2m to € 12m in SMEs with turnover of more than € 2m, profitable or close to being and having demonstrated their interoperability with the solutions in place, with the aim of enabling them to to realize their growth potential. These SMEs are selected for their value creation potential through development of supply, geographic expansion or implementation of strategic partnerships.

The focus on e-health aims at an accurate knowledge of the market, of its players, of its opportunities, of its risks and thus to target investments, to accompany efficiently companies of the portfolio and to help them to maximize their valuation.

Extens wants to be actively involved in monitoring its portfolio by supporting strategic thinking, creating business opportunities and helping management to anticipate operational issues related to strong growth. To date, Extens has acquired stakes in Enovacom, an interoperability software vendor (sold in February 2018 to Orange Healthcare); Kayentis, clinical trial data collection platform; Must, ERP for home health providers; Discngine, research software for life science; Teranga, patient record in Ehpad and Bow Medical, management software for anesthesia care and resuscitation.

About Capital Croissance:

Capital Croissance is a private equity firm approved by the AMF with over € 400 million under management. It manages funds of entrepreneurs who invest throughout transmission operations (MBO, OBO, etc.) or growth capital from 5 to 50 M €, in French SMEs realizing up to € 250 million turnover. Funded by a community of more than 200 private investors (entrepreneurs, families, business leaders, etc.), as well as by Bpifrance and AXA France, Capital Croissance is a value-added partner for entrepreneurs, which helps them grow faster and better. go further in their ambitions, in France and internationally.

Capital Croissance invested in 17 SMEs including BIOBank (bone grafts), Altima (digital agency specialized in e-commerce), HL Trad (translation agency specialized in law and finance), Babyzen (strollers for children), SPAS Organization (trade fairs for organic and well-being sectors), GM Consultant (insurance claims expertise), iD Systems (software for the wine and horticultural sector) and Teaminside (digital transformation consulting).

About Bpifrance:

Bpifrance equity investments are made by Bpifrance Investissement. Bpifrance finances companies – at every stage of their development – in credit, guarantee and equity. Bpifrance accompanies them in their innovation projects and internationally. Bpifrance also ensures their export activity through a wide range of products. Advice, university, networking and acceleration program for startups, SMEs and midcaps are also part of the offer to entrepreneurs.
Thanks to Bpifrance and its 48 regional locations, entrepreneurs benefit from a close, unique and effective interlocutor to help them face their challenges.
More information on: – 
Follow us on Twitter: @Bpifrance – @BpifrancePress

Press contacts:

For Bpifrance:
Christophe Menger
Tel. : 01 41 79 95 12

For Extens:
Cédric Berger

2019-11-07T15:40:14+02:00novembre 7th, 2019|